1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Biogen Idec Inc. (BIIB): New Analyst Report from Zacks Equity Research – Zacks … – NASDAQ

December 5, 2013Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

Biogen Idec Inc. (BIIB): New Analyst Report from Zacks Equity Research - Zacks ...
NASDAQ
The company has collaborations with companies like Roche (Rituxan), Acorda (Fampyra), Biovitrum (Eloctate and Alprolix) and AbbVie (daclizumab) among others. In terms of infrastructure, Biogen has substantial manufacturing, research and development ...

and more »

Post navigation

← Heart Failure After Heart Attack Is Driven by Immune Cells Made in Spleen – Science Daily (press release) Hypothalamic-Pituitary-Adrenal Axis Recovery Following Prolonged … – Journal of Clinical Endocrinology and Metabolism →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos